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Available online xxxxBackground: G-quadruplexes (G4s) are four-stranded nucleic acid structures that form in G-rich sequences.
Nucleolin (NCL) is a cellular protein reported for its functions upon G4 recognition, such as induction of neuro-
degenerative diseases, tumor and virusmechanisms activation.Wehere aimedat deﬁningNCL/G4 binding deter-
minants.
Methods: Electrophoresismobility shift assaywas used to detect NCL/G4 binding; circular dichroism to assess G4
folding, topology and stability; dimethylsulfate footprinting to detect G bases involved in G4 folding.
Results: The puriﬁed full-length human NCL was initially tested on telomeric G4 target sequences to allow for
modulation of loop, conformation, length, G-tract number, stability. G4s in promoter regionswithmore complex
sequenceswere next employed.We found thatNCL binding to G4s heavily relies onG4 loop length, independent-
ly of the conformation and oligonucleotide/loop sequence. Low stability G4s are preferred. When alternative G4
conformations are possible, thosewith longer loops are preferred upon binding toNCL, even if G-tracts need to be
spared from G4 folding.
Conclusions: Our data provide insight into how G4s and the associated proteins may control the ON/OFF molec-
ular switch to several pathological processes, including neurodegeneration, tumor and virus activation. Under-
standing these regulatory determinants is the ﬁrst step towards the development of targeted therapies.
General signiﬁcance: The indication that NCL binding preferentially stimulates and induces folding of G4s contain-
ing long loops suggests NCL ability to modify the overall structure and steric hindrance of the involved nucleic
acid regions. This protein-induced modiﬁcation of the G4 structure may represent a cellular mechanosensor
mechanism to molecular signaling and disease pathogenesis.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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G-quadruplexes (G4s) are unique four-stranded nucleic acid struc-
tures that may form in guanine-rich sequences [1]. Four Gs bind via
Hoogsteen-type hydrogen bonds to yield G-quartets that in turn stack
on top of each other to form the G4. The presence of K+ cations specif-
ically supports G4 formation and stability. G4s are highly polymorphic,
in terms of strand stoichiometry (forming both inter- and intramolecu-
lar structures), strand orientation/topology and loop sequence, length
and position [2]. G4s have been shown in humans and other eukaryotes
[3,4], in prokaryotes [5–8] and in viruses [9,10]. From a functional point
of view, in humans G4s play key regulatory and pathological roles,CL; circular dichroism, CD;
of melting, Tm; dimethylsulfate,
. This is an open access article under
cellular protein nucleolin pr
16/j.bbagen.2016.11.036including transcriptional regulation of gene promoters and enhancers,
translation, chromatin epigenetic regulation, DNA recombination [11–
13]. HumanG4DNAmotifs have been reported to be associatedwith re-
combination prone regions [14] and to show mutational patterns that
preserved the potential to form G4 DNA structures [15]. G4
misregulation has been associated with a number of relevant human
diseases, such as the amyotrophic lateral sclerosis [16], Alzheimer [17]
and fragile X syndrome [18], in which expansion of G4-forming regions
has been reported. In viruses, G4s have been proposed both as virus
cycle modulators and antiviral targets [10]. In the human immunodeﬁ-
ciency virus-1 (HIV-1), the etiologic agent of the acquired immune de-
ﬁciency syndrome (AIDS), functionally signiﬁcant G4s in the Nef
coding region [19] and in the unique long terminal repeat (LTR) pro-
moter [20–22] have been identiﬁed. These studies have shown that
G4 folding at the LTR promoter decreases viral transcription with an ef-
fect that is augmented by G4 ligands [23,24]. G4s have also been report-
ed in the herpes simplex virus 1 [25], Epstein–Barr virus [26,27], SARS
coronavirus [28], human papilloma, hepatitis C, Zika and Ebola virus ge-
nomes [29,30,31,32].the CC BY license (http://creativecommons.org/licenses/by/4.0/).
eferentially binds long-looped G-quadruplex nucleic acids, Biochim.
Table 1
Sequences of oligonucleotides used in this study.
Name Length (nts) Sequence 5′-3′’
(GGGTTA)4 21 GGGTTAGGGTTAGGGTTAGGG
(GGGTTA)6 36 GGGTTAGGGTTAGGGTTAGGGTTAGGGTTAGGGTTA
(GGGTTA)8 54 TCGAGGGTTAGGGTTAGGGTTAGGGTTAGGGTTAGGGTTAGGGTTAGGGTTAC
(GGGTTT)4 21 GGGTTTGGGTTTGGGTTTGGG
(GGGTTT)6 36 GGGTTTGGGTTTGGGTTTGGGTTTGGGTTTGGGTTT
(GGGTTT)8 48 GGGTTTGGGTTTGGGTTTGGGTTTGGGTTTGGGTTTGGGTTTGGGTTT
(GGGTTT)5 27 GGGTTTGGGTTTGGGTTTGGGTTTGGG
n5M1 27 TTTTTTGGGTTTGGGTTTGGGTTTGGG
n5M2 27 GGGTTTTTTTTTGGGTTTGGGTTTGGG
n5M3 27 GGGTTTGGGTTTTTTTTTGGGTTTGGG
n5M4 27 GGGTTTGGGTTTGGGTTTTTTTTTGGG
n5M5 27 GGGTTTGGGTTTGGGTTTGGGTTTTTT
M43 43 TTTTTGGAGTCGTGTCGCGTGTCGAGCGTGTGTAGTGGTTTTT
M30 30 TTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
M29i 29 AAAACAGACAGCTCACTGCGCTCACAAAA
M29ii 29 TTTTGTGAGCGCGGTGAGGTGTGTGTTTT
M26 26 CCTCCTCCTCCTTCTCCTCCTCCTCC
M21 21 TTTTTTTTTTTTTTTTTTTTT
M14 14 CGGCATGCGTGGCT
111 15 GGGTGGGTGGGTGGG
131 17 GGGTGGGTTTGGGTGGG
161 20 GGGTGGGTTTTTTGGGTGGG
313 19 GGGTTTGGGTGGGTTTGGG
333 21 GGGTTTGGGTTTGGGTTTGGG
363 24 GGGTTTGGGTTTTTTGGGTTTGGG
616 25 GGGTTTTTTGGGTGGGTTTTTTGGG
636 27 GGGTTTTTTGGGTTTGGGTTTTTTGGG
666 30 GGGTTTTTTGGGTTTTTTGGGTTTTTTGGG
T111T 17 TGGGTGGGTGGGTGGGT
T131T 19 TGGGTGGGTTTGGGTGGGT
T161T 22 TGGGTGGGTTTTTTGGGTGGGT
c-kit1 21 AGGGAGGGCGCTGGGAGGAGG
bcl-2 39 AGGGGCGGGCGCGGGAGGAAGGGGGCGGGAGCGGGGCTG
c-myc 27 TGGGGAGGGTGGGGAGGGTGGGGAAGG
hTert 1–4 20 AGGGGAGGGGCTGGGAGGGC
hTert 5–12 46 AGGGGGCTGGGCCGGGGACCCGGGAGGGGTCGGGACGGGGCGGGGT
hTert 1–12 70 AGGGGAGGGGCTGGGAGGGCCCGGAGGGGGCTGGGCCGGGGACCCGGGAGGGGTCGGGACGGGGCGGGGT
2 S. Lago et al. / Biochimica et Biophysica Acta xxx (2016) xxx–xxxThe biological effects of G4s are often modulated by the interaction
with proteins [33]: the shelterin complex proteins are involved in telo-
mere homeostasis [34], and other G4 interacting proteins either unfold
or stabilize the G4 conformation [35,36].Mutations in someof theseG4-
interacting proteins have been linked to genetic diseases, such as the
Bloom's and Werner's syndromes, Fanconi anemia [37,38], and cancer
[39].
Among G4 interacting proteins, nucleolin (NCL) is the protein
most often reported for its biological functions upon G4 recognition.
It is widely believed that NCL plays a chaperone role by helping the
correct folding of complex nucleic acids structures. Indeed, NCL has
been shown to display a marked preference for both endogenous
and exogenous G-rich sequences that can fold into G4 [40]. It has
been reported that binding of NCL to the endogenous (GGGGCC)n
hexanucleotide repeat expansion (HRE) in C9orf72 is responsible
for the initiation of molecular cascades that lead to neurodegenera-
tive diseases [16]. At the promoter level, binding of NCL to G4 struc-
tures augments the basal effect of the folded conformation [41–44].
For example, in the case of HIV-1, it induces potent inhibition of
viral transcription by stabilization of the LTR promoter [45]. NCL is
mainly present in the nucleolus, but it can be found also in cell mem-
branes and, upon stress stimuli, in the nucleoplasm and cytoplasm to
some extent [46,47]. NCL has been initially described as a RNA bind-
ing protein, but recent evidence indicates the relevance, and in some
case the preference, of its binding to DNA structures [45]. Because of
NCL role in viral mechanisms, such as HIV cell attachment/entry and
budding [48–50] and virus replication and transcription [51–56],
NCL inhibitors have been developed [57–59]. Interestingly, one of
these is a G4-forming oligonucleotide, which displays interesting
HIV activity [60,61].Please cite this article as: S. Lago, et al., The cellular protein nucleolin pr
Biophys. Acta (2016), http://dx.doi.org/10.1016/j.bbagen.2016.11.036Despite the involvement of NCL/G4 complex in several human dis-
eases, a deep understanding of the G4 structural features that drive
binding to NCL is lacking. A certain degree of selectivity towards nucleic
acids has been reported [41,45]. For instance, in the case of the HIV-1
LTR promoter, where three G4s can form (LTR-II, LTR-III and LTR-IV),
NCL binds with high afﬁnity to LTR-III and with intermediate afﬁnity
to LTR-II, whereas LTR-IV is not recognized [45].
To understand the structural requirements that stimulate NCL bind-
ing to G4s, we tested NCL binding towards different sets of G4 oligonu-
cleotides, considering loop length, topology, sequence, number of G-
runs, stability. We found that loop length was always the prevalent de-
terminant of NCL binding to G4s, independently of the conformation
and oligonucleotide/loop sequence. These ﬁndings both allow a deeper
understanding of NCL/G4-regulated physiological and pathological
mechanisms, and the possibility to develop new target-speciﬁc drugs.
2. Materials and methods
2.1. Oligonucleotides and proteins
Desalted oligonucleotides were purchased from Sigma-Aldrich
(Milan, Italy). Oligonucleotides were denatured for 5 min at 95 °C and
gradually cooled to room temperature to achieve proper G4 folding.
The human recombinant nucleolin (NCL) is from Origene Technologies,
Rockville, USA.
2.2. Circular dichroism (CD)
CD spectroscopy was used to probe G4 folding and conformation of
the tested DNA oligonucleotides. Oligonucleotides were diluted to aeferentially binds long-looped G-quadruplex nucleic acids, Biochim.
AB
C
Fig. 1.NCL binding to G4s with increasing number of G-tracts. (A) CD spectra of telomeric
sequences (GGGTTA)n and (GGGTTT)n, where n = 4, 6 and 8. (B) EMSA analysis of NCL
binding to telomeric sequences (GGGTTA)n - lane 4, 5, 6 left - and (GGGTTT)n - lane 4, 5,
6 right -. Lanes 1–4 are control reactions without NCL. (C) Quantiﬁcation of NCL/G4
complex bands obtained in the EMSA shown in panel (B). Binding of lanes 4–6 left and
4–6 right was normalized for (GGGTTA)4 and (GGGTTT)4 NCL/G4 band intensity,
respectively.
3S. Lago et al. / Biochimica et Biophysica Acta xxx (2016) xxx–xxxﬁnal concentration of 4 μM in lithium cacodylate buffer (10 mM,
pH 7.4), KCl or NaCl (100 mM) and 20% of PEG200 where indicated.
After heat denaturation sampleswere folded at room temperature over-
night. CD spectra were recorded on a Chirascan-Plus (applied
Photophysics, Leatherhead, UK) equipped with a Peltier temperature
controller using a quartz cell of 5 mm optical path length and an instru-
ment scanning speed of 50 nm/min. The temperature was set at 20 °C
and the spectra were recorded over a wavelength range of 230–
320 nm. For Tm determination, spectra were recorded over a tempera-
ture range of 20–95 °C,with temperature increase of 5 °C/min. Tm values
were calculated according to the van't Hoff equation, applied for a two-
state transition from a folded to unfolded state. Acquired spectra were
baseline corrected for signal contribution due to the buffer and the ob-
served ellipticities converted to mean residue ellipticity (θ) =
deg × cm2 × dmol−1 (mol ellip).
2.3. Electrophoresis Mobility Shift Assay (EMSA)
EMSA was used to detect G4-NCL interaction and the stoichiometry
of G4 folding. Oligonucleotides were 5′-end labeled with [γ-32P]ATP by
T4 polynucleotide kinase after 30 min incubation at 37 °C. After DNA
precipitation, labeled species were resuspended in lithium cacodylate
buffer (10 mM, pH 7.4, KCl 100 mM or NaCl 100 mM and 20% (w/v)
PEG200 where indicated), heat denatured and folded at room
temperature.
For the determination of G4 stoichiometry samples were run in 20%
non-denaturing polyacrylamide gels for ~24 h at 60 V. Gels were fresh
impressed and visualized by phosphorimaging (Typhoon FLA 9000, GE
Healthcare Europe, Milan, Italy).
For NCL binding to DNA, reactions were performed in binding buffer
(Tris–HCl 20 mM pH 8, KCl 30 mM, MgCl2 1.5 nM, DTT 1 mM, glycerol
8%, protease inhibitor cocktail – Sigma Aldrich, Milan, Italy – 1%, NaF
5mM,Na3VO4 1mM), labeled oligonucleotides (40 nM), human recom-
binant NCL (300 ng) and incubated for 1 h at 37 °C. Binding reactions
were supplemented with 20% (w/v) PEG200 where indicated. To load
the same amount of DNA in each reaction, counts per second emitted
by the radiolabeled oligonucleotides were measured by a Geiger coun-
ter (Mini 900 Scintillation Monitor, Thermo Scientiﬁc™, Monza, Italy).
Samples were loaded on 8% non-denaturing polyacrylamide gels for
~15 h at 40 V. Gels were dried using a gel dryer (Bio Rad Laboratpries,
Milan, Italy) and visualized by phosphorimaging (Typhoon FLA 9000,
GE Healthcare Europe, Milan, Italy). Quantiﬁcation of bound DNAmole-
cules was performed by ImageQuant TL Software (GE Healthcare Eu-
rope, Milan, Italy). Each gel was performed twice to conﬁrm
quantiﬁcation results; only results consistent throughout the repeated
gels were retained and reported.
2.4. Dimethylsulfate footprinting (DMS)
The DNA substrate of interest was gel-puriﬁed before use, 5′-end-la-
beled with [γ-32P]ATP by T4 polynucleotide kinase, puriﬁed using
MicroSpin G-25 columns (GE Healthcare Europe, Milan, Italy), resus-
pended in lithium cacodylate buffer 10 mM pH 7.4 with or without
KCl 100 mM, heat denatured and folded. Sample solutions were then
treated with dimethylsulfate (DMS, 0.5% in ethanol) for 5 min and
stopped by addition of 10% glycerol and β-mercaptoethanol. Samples
were loaded onto a 16% native polyacrylamide gel and run until the de-
sired resolution was obtained. DNA bands were localized via autoradi-
ography, excised and eluted overnight. The supernatants were
recovered, ethanol-precipitated and treated with piperidine 1 M for
30 min at 90 °C. Samples were dried in a speed-vac, washed with
water, dried again, and resuspended in formamide gel loading buffer.
Reaction products were analyzed on 20% denaturing polyacrylamide
gels, visualized by phosphorimaging analysis, and quantiﬁed by
ImageQuant TL software (GE Healthcare Europe, Milan, Italy).Please cite this article as: S. Lago, et al., The cellular protein nucleolin pr
Biophys. Acta (2016), http://dx.doi.org/10.1016/j.bbagen.2016.11.0363. Results
3.1. Nucleolin binding to G-quadruplexes directly correlates with the num-
ber of G-tracts
To investigate the determinants required for efﬁcient NCL binding, we
initially tested the human telomeric sequence, formed by GGGTTA re-
peats, and a simpliﬁed sequence formed by GGGTTT repeats, which iseferentially binds long-looped G-quadruplex nucleic acids, Biochim.
Table 2
Stability (Tm values) of oligonucleotides of the (GGGTTT)5 series with G-tracts replaced
with Ts. Tmweremeasuredby CD thermal unfolding and reported at the positive CDpeaks,
signatures of the parallel (265 nm) and antiparallel (285 nm) G4 conformation
contribution.
Oligonucleotide Tm (265 nm) (°C) Tm (285 nm) (°C)
(GGGTTT)4 66.6 ± 0.4 66.1 ± 0.4
(GGGTTT)5 65.5 ± 1.1 64.5 ± 0.5
n5M1 58.0 ± 0.8 55.7 ± 0.5
n5M2 53.4 ± 0.5 54.5 ± 0.2
n5M3 56.7 ± 0.3 56.6 ± 0.1
n5M4 52.0 ± 0.3 53.2 ± 0.1
n5M5 / 60.4 ± 0.4
4 S. Lago et al. / Biochimica et Biophysica Acta xxx (2016) xxx–xxxfound in telomeres of ciliates of the genus Paramecium [62]. The interac-
tion of NCL and its four RNA binding domains (RBD) and the Arg-Gly-Gly
(RGG) domain to telomeric G4s has been previously reported [41,63,64].
Telomeric sequences are rather simple compared to the G4 sequences in
oncogene and HIV-1 promoters and were thus chosen to allow assess-
ment of oligonucleotide length, loops, repeats, conformation and se-
quence contribution to NCL binding. NCL/oligonucleotide binding was
tested by electrophoresis mobility shift assays (EMSA) with 32P-labelled
nucleic acids and the puriﬁed full-length human NCL protein [45].
We initially tested telomeric sequences ((GGGTTA)n and
(GGGTTT)n) with increasing number of G-tracts, i.e. n = 4, 6 and 8
(Table 1).
All sequences folded into mixed type G4s as assessed by circular di-
chroism (CD) analysis: in fact, all oligonucleotides displayed positive
peaks around 290 nm and 260 nm, which are signatures of hybrid/
mixed type G4 topologies (Fig. 1A). NCL binding to the G4 oligonucleo-
tides was visualized as two bands running slower than the free un-
bound DNA. The presence of the two bands has been previously
demonstrated to be due to the N-terminus self-cleaving activity of
NCL [45]: thus the two bands were ascribed to the binding of the full-
length (upper) and the N-terminus-minus (lower) NCL protein to the
G4s (Fig. 1B). In these conditions, NCL bindingwas directly proportional
to the length of the telomeric sequences and the difference in loop se-
quence between human and ciliate G4s did not modify this trend (Fig.
1C).A
C
Fig. 2.Analysis of NCLbinding to alternativeG4 structures formed by the (GGGTTT)5 telomeric se
M is a marker lane obtained with the Maxam and Gilbert sequencing protocol. Oligonucle
quantiﬁcation of cleaved bands intensity. (B) CD spectra of (GGGTTT)5 and mutant derivatives
to (GGGTTT)4, (GGGTTT)5 and mutant oligonucleotides. Oligonucleotide identity is shown ab
the EMSA in panel (C). n4 and n5 stand for (GGGTTT)4 and (GGGTTT)5, respectively.
Please cite this article as: S. Lago, et al., The cellular protein nucleolin pr
Biophys. Acta (2016), http://dx.doi.org/10.1016/j.bbagen.2016.11.0363.2. Long loops favor NCL binding to G4s
While the sequences with 4 and 8 G-tracts can fold into 1 and 2
stacked G4s, respectively, sequences with 5 and 6 G-tracts can fold
into oneG4 structure leaving one or two spare G-tracts. To testwhether
therewas a preferred involvement of G-tracts in these conformationally
dynamic sequences, oligonucleotide (GGGTTT)5 (Table 1) was folded in
the presence and absence of K+ and treated with DMS to highlight G
bases protected from DMS-induced methylation when in the G4 folded
state. The analysis showed that all Gs were equally protected during
folding (Fig. 2A) indicating the equilibrium of multiple G4 structuresB
D
quence (A)DMSprotection analysis of (GGGTTT)5 folded in the presence or absence of K+.
otide sequence is shown below the gel image. The densitogram above the gel shows
where each G-tract was systematically replaced by Ts. (C) EMSA analysis of NCL binding
ove each lane in the gel image. (D) Quantiﬁcation of NCL/G4 complex bands obtained in
eferentially binds long-looped G-quadruplex nucleic acids, Biochim.
Table 3
Stability (Tm values) of oligonucleotides of the (GGGTTT)4 series with variable-length
loops. Tm were measured by CD thermal unfolding and reported at the positive CD peaks,
signatures of the parallel (265 nm) and antiparallel (285 nm) G4 conformation
contribution.
Oligonucleotide Tm (265 nm) (°C) Tm (285 nm) (°C)
111 N90 /
131 N90 /
161 72.1 ± 0.3 /
313 66.1 ± 0.4 /
333 66.6 ± 0.4 66.1 ± 0.4
363 63.0 ± 0.2 64.0 ± 0.2
616 52.7 ± 0.1 /
636 52.9 ± 0.3 53.0 ± 0.1
666 45.3 ± 0.3 44.4 ± 0.1
5S. Lago et al. / Biochimica et Biophysica Acta xxx (2016) xxx–xxxthat involved alternative G-tracts. Similar results have been previously
reported [65]. In particular, in the case of the (GGGTTT)5 oligonucleo-
tide, 5 alternative G4 structures, which comprise G-tracts 1-2-3-4, 2-
3-4-5, 1-3-4-5, 1-2-4-5, 1-2-3-5, may be envisaged. To test NCL binding
to each of these sequences,mutant oligonucleotideswhere eachG-tract
was replaced by Ts were employed (Table 1). The (GGGTTT)4 oligonu-
cleotide was used as a control since it displays the same sequence and
number of G-tracts as the mutant oligonucleotides, but lacks extra T
bases in the loops or at the 5′- or 3′-end (Table 1). All mutant sequences
were shown tomaintain theG4 folding by CD analysis: oligonucleotides
displayed mainly a hybrid/mixed type topology with different levels of
parallel/antiparallel contributions (Fig. 2B). The stability of the mutant
sequences forming internal long loops was slightly lower than that of
thewild-type sequence, as gathered by Tmelting (Tm) valuesmeasured
by CD thermal unfolding (Table 2).
EMSA analysis of NCL binding to themutant sequences showedmild
preferential binding towards oligonucleotides where internal G-tracts
were mutated (Fig. 2C and D). Binding to sequences with external Ts
was consistently lower, but higher than that to the (GGGTTT)4 control.
The (GGGTTT)5 oligonucleotide displayed an average binding to all
other mutant sequences. These data indicate that NCL preferentially
binds G4s with at least one loop longer than 3 nts (e.g. 9 nts, compare
n5M2, n5M3 and n5M4 binding, lanes 4–6 NCL, to n5M1 and n5M5,
lanes 3 and 7 NCL, Fig. 2C) andwith free nts at the 5′ or 3′ termini (com-
pare n5M1, lane 3NCL, and n5M5, lane 7NCL, to (GGGTTT)4, lane 1NCL,
Fig. 2C).A B
D C
Fig. 3.NCL binding to G4swith systematic elongation of loop length. (A) CD spectra of oligonucle
EMSA analysis of NCL binding to each G4 with different loop-length combination. Oligonucl
obtained in the EMSA in panel (B). (D) Native gel electrophoresis of G4-folded oligonuc
oligonucleotides of known length and unable to fold into secondary structures. The symbol * in
Please cite this article as: S. Lago, et al., The cellular protein nucleolin pr
Biophys. Acta (2016), http://dx.doi.org/10.1016/j.bbagen.2016.11.0363.3. More than two long or extremely short loops destabilize NCL interac-
tion with G4s
To explore the impact of loop length onNCL binding toG4s, three se-
ries of oligonucleotides with different loop-length combinations were
tested: in each series, the two lateral loops were kept constant (1, 3 or
6 nts in each series) and the central loop was modiﬁed (1, 3 or 6 nts)
(Table 1). All oligonucleotides folded into G4: in this case some se-
quences displayed a neat parallel topology (111, 131, 161, 313, 616,
Fig. 3A), while other a mixed/hybrid type one (333, 363, 636, 666, Fig.
3A), in keepingwith the notion that G4swith 1-nt loops are constrainedotideswith two constant lateral (1, 3 or 6 nts) and variable central loops (1, 3 or 6 nts). (B)
eotides identity is shown above each lane. (C) Quantiﬁcation of NCL/G4 complex bands
leotides. Oligonucleotides identity is shown above each lane. Lanes 1–4 are marker
dicates oligonucleotides showing two bands with different migration rate.
eferentially binds long-looped G-quadruplex nucleic acids, Biochim.
A B
C
D
Fig. 4. Analysis of monomeric and dimeric G4 folding of relevant oligonucleotides. (A) Native gel electrophoresis at increasing oligonucleotide concentration (20, 45, 120, 415, 1600,
6200 nM). Samples identity is indicated above the gel image. Marker oligonucleotides with known length and unable to fold into secondary structures are loaded. (B) CD spectra of
G4s showing dimeric folding and their corresponding monomolecular form when one T base was added at each of the two ends. (C) EMSA analysis of NCL binding. Oligonucleotides
identity is shown above each lane. (D) Quantiﬁcation of NCL/G4 complex bands obtained in the EMSA in panel (C).
6 S. Lago et al. / Biochimica et Biophysica Acta xxx (2016) xxx–xxxto the parallel conformation [66,67]. In general, G4s with shorter loops
were more stable than those with longer loops (Table 3).
EMSA binding analysis showed a general increase in NCL binding
upon loop extension. In particular, considering the series where the lat-
eral loopswere kept constant, an increase in bindingwas observedwith
the increasing length of the central loop; in the series where the central
loopwas kept constant, an increased bindingwas observed upon the in-
creasing length of the lateral loops (Fig. 3B and C). Two notable excep-
tions were found: when all loops were 1 nt- or 6-nt long, NCL binding
was higher or lower, respectively, than expected by the above-de-
scribed trend (oligonucleotides 111 and 666 in Fig. 3B and C).
The observed behavior was apparently independent of the G4 con-
formation: oligonucleotides adopted both mixed and parallel-like G4
conformations (Fig. 3A), while no straightforward correlation with the
intensity of NCL binding could be found (Fig. 3B and C). However,Please cite this article as: S. Lago, et al., The cellular protein nucleolin pr
Biophys. Acta (2016), http://dx.doi.org/10.1016/j.bbagen.2016.11.036when testing G4 folding in EMSA,we observed onemain band for all ol-
igonucleotides, except oligonucleotides 111 and 131, which displayed
two bands running at different migration rates (Fig. 3D). To test the
molecularity of the upper running band, each labeled oligonucleotide
was added with increasing amounts of the same unlabeled nucleic
acid. As shown in Fig. 4A, the amount of the upper running band in-
creasedwith increasing amounts of the unlabeled oligonucleotide, indi-
cating the dimeric nature of the upper band. It has been reported that
the presence of one T base at the end of a G4 forming oligonucleotide in-
duces a preferential monomeric G4 [68,69]. Indeed, when one T base
was added at each end of the 111, 131 and 161 oligonucleotides
(T111T, T131T, T161T, Table 1), the oligonucleotides maintained the
G4 conformation (Fig. 4B) and only the monomeric faster running
band was obtained (Fig. 4C). These T-added oligonucleotides bound
NCL to a lower extent than those without T, probably due to stericeferentially binds long-looped G-quadruplex nucleic acids, Biochim.
AB
C
Fig. 5. Analysis of NCL binding towards oligonucleotides with variable G4s conformation.
(A) CD spectra of 313, 333, 363 oligonucleotides folded in the presence of 20% (w/v)
PEG200 and K+ or Na+. (B) EMSA analysis of NCL binding to 313, 333, 363
oligonucleotides folded in the presence of 20% (w/v) PEG200 and K+ or Na+ as
indicated above the gel image. (C) Quantiﬁcation of NCL/G4 complex bands obtained in
the EMSA in panel (B). For the K+ or Na+ experiment series, binding was normalized to
the intensity of the 333 NCL/G4 complex band in the corresponding salt condition.
7S. Lago et al. / Biochimica et Biophysica Acta xxx (2016) xxx–xxxhindrance, however, the binding trendwas restored: the increase in the
amount of NCL/DNA complex paralleled the lengthening of the loops
(Fig. 4D).
The above data indicate that in G4-forming sequences formed by
GGG tracts and T loops, NCL binding is in general favored by the pres-
ence of one or two long loops (i.e. 6 nt), whereas three long loops arePlease cite this article as: S. Lago, et al., The cellular protein nucleolin pr
Biophys. Acta (2016), http://dx.doi.org/10.1016/j.bbagen.2016.11.036less favored. The presence of one or two 1-nt long loops in the absence
of at least one 6-nt loops disfavors NCL binding.
3.4. NCL binding to G4 oligonucleotides is independent of the G4
conformation
It has been reported that oligonucleotide G4 folding depends on the
presence of the monovalent cation in solution. For instance, the human
telomeric sequence adopts a hybrid conformation in K+ solution [70],
while it is antiparallel in a Na+ solution [71]. Moreover, the presence
in solution of cosolvents, such as polyethylene glycol (PEG), during G4
folding is commonly used to perturb G4 topology [72]. The human
telomeric G4 DNA in the presence of PEG is reported to adopt a parallel
G4 conformation, which is not the predominant form in dilute solutions
[73–76]. To investigate the effect of G4 conformation on NCL binding,
we folded oligonucleotides previously tested in KCl alone (Fig. 3B), in
KCl and NaCl in the presence of PEG 20% (w/v). In these conditions we
observed in most cases a clear-cut conformational change (Fig. 5A):
for instance, oligonucleotide 333wasmixed with a prevalent antiparal-
lel conformation in K+, while it shifted to a prevalent parallel topology
in K+ + PEG (compare Figs. 3A and 5A). The binding of NCL was
assessed on these oligonucleotides folded in PEG (Fig. 5B).We observed
themaintenance of the increased NCL binding to longer loop sequences
trend (Fig. 5C). These data indicate that binding of NCL to telomeric G4
oligonucleotides is in general independent of the conformation and that
loop length is the major determinant of NCL binding efﬁciency to
telomeric G4s.
3.5. Sequence dependence: NCL binding to oncogenes promoter G4s
To verify if NCL binding determinants observed in telomeric
(GGGTTT)n G4sweremaintained in G4s withmore complex sequences,
we tested NCL binding towards four oncogene promoters i.e. c-myc, c-
kit1, bcl-2 and hTert 1–4 [77–80]. These were shown to form stable
G4s whose conformations have been characterized by deep structural
analysis. All these oncogene promoter G4s display loops with different
length, composition and conformation (Table 1 and Fig. 6A). NCL
bound preferentially to bcl-2, followed by c-myc; hTert 1–4 and c-kit1
displayed similar and lower NCL binding (Fig. 6B and C). Among these
G4s, bcl-2 is the only structure exhibiting a long loop (7 nts) and two
shorter loops (3 and 1 nts), whereas c-myc, c-kit1 and hTert 1–4 they
all have loops ≤4 nts (Table 1).
It has very recently been shown that the hTert full-length sequence
is composed of 12 G-tracts that fold in two adjacent G4s: our tested
hTert 1–4 comprises the ﬁrst four G-tracts; the second G4, spanning
G-tracts 5–12, displays a peculiar structure where a 26 nt-long loop
forms an extended stem-hairpin [81]. We wished to test NCL binding
to the two separate hTert G4s (hTert 1–4 and hTert 5–12) and to the
full-length sequence (hTert 1–12). All three hTert G4s have similar CD
spectra with a major peak at 260 nm and a shoulder at 295 nm, with
molar ellipticity values at 260 nm increasing with the number of G-
tracts in the G4-forming oligonucleotides (Fig. 7A). NCL binding to
hTert 1–4 and hTert 5–12 was similar, indicating that the stem-hairpin
suppresses the enhancing binding effect of the long loop (Fig. 7B and C).
Binding of NCL to hTert 1–12 was slightly enhanced (Fig. 7B and C),
retracing the behavior observed in the (GGGTTA)n and (GGGTTT)n oli-
gonucleotides, where NCL preferentially bound to oligonucleotides
with longer loops when multiple G-tracts were available for folding
(Figs. 1 and 2). It is thus possible that also in the case of hTert 1–12
NCL induces folding of a less stable but favorite long-looped G4. In alter-
native, the 7 nt spacer between the twoG4 s (hTert 1–4 and hTert 5–12)
is recognized as a long loop and therefore stimulates NCL binding. We
next tested bcl-2 and c-myc in the presence of PEG 20% (w/v) to rule
out an effect of PEG in NCL binding. Both oligonucleotides in K+ are
folded in a parallel G4 conformation, which is not modiﬁed in the pres-
ence of PEG (Fig. 7D). NCL maintained a similar trend and degree ofeferentially binds long-looped G-quadruplex nucleic acids, Biochim.
A B C
Fig. 6. NCL binding to human oncogene promoter G4s. (A) CD spectra of G4s formed in the c-kit1, bcl-2, c-myc and hTert 1–4 promoters. (B) EMSA analysis of NCL binding to oncogene
promoter G4s. (C) Quantiﬁcation of NCL/G4 complexes obtained in the EMSA in panel (B).
8 S. Lago et al. / Biochimica et Biophysica Acta xxx (2016) xxx–xxxbinding to these G4s in the absence/presence of PEG, conﬁrming that
PEG did not signiﬁcantly alter NCL binding (Fig. 7E).
These data are in prefect agreement with the NCL binding trend ob-
served in telomeric (GGGTTT)n G4s. In addition, they also ﬁt with NCL
binding to HIV-1 LTR promoter G4s, previously reported and obtained
by both EMSA and FRET analysis [45]. In that case, as well, the bestA B
D E
Fig. 7.NCL binding to G4s in special conditions. (A) CD spectra of G4s formed by hTert 1–4, hTe
NCL binding to hTert G4s. (C) Quantiﬁcation of NCL/G4 complexes obtained in the EMSA in pane
(w/v). (E) EMSA analysis of NCL binding to c-myc and bcl-2 G4s in the presence/absence of PE
Please cite this article as: S. Lago, et al., The cellular protein nucleolin pr
Biophys. Acta (2016), http://dx.doi.org/10.1016/j.bbagen.2016.11.036bound G4 LTR-III displayed 1, 11, 3 nt-long loops, followed by LTR-II
with 8, 11, 1 nt-long loops; in contrast LTR-IV, which presented 1, 4,
1 nt-long loops, was bound to a negligible extent [21,45].
These data indicate that the results collected on (GGGTTT)n G4s
apply in general to G4s with random sequences and that, again, the
loop length is the major determinant in driving NCL binding to G4s.C
F
rt 5–12 and hTert 1–12 oligonucleotides. Numbers indicate G4-tracts. (B) EMSA analysis of
l (B). (D) CD spectra of G4s formed by c-myc and bcl-2 in the presence/absence of PEG 20%
G 20% (w/v). (F) Quantiﬁcation of NCL/G4 complexes obtained in the EMSA in panel (E).
eferentially binds long-looped G-quadruplex nucleic acids, Biochim.
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Despite the fact that NCL binding to G4 nucleic acids has been pro-
posed to be responsible for human neurodegenerative diseases [16],
pathological molecular mechanisms in cells [41–44] and viruses [48–
56], a deep characterization of the G4 features that induce NCL binding
have been attempted only by Gonzalez et al. [41]. This group, who per-
formed pioneer studies on NCL binding to the oncogene promoter c-
myc G4, reported a preferential binding of NCL to parallel G4s with
short loops. In contrast, our present work indicates that long loops in
the G4 structure are preferred and this behavior is independent of the
G4 conformation or loop/oligonucleotide sequence. These apparent dif-
ferences may be explained by several reasons: 1) the use of a recombi-
nant NCL puriﬁed in bacteria [41] vs the full-length human NCL puriﬁed
from human cells (this work): the recombinant protein included all
RBDs and C-terminal domain of the natural human protein but lacked
the N-terminal domain which in turn was fused to the Escherichia coli
maltose-binding protein; even if the nucleic acid binding activity was
maintained in these conditions, the speciﬁc recognition of G4s, and in
particular of their steric features,may be severely distorted by the intro-
duction of a different N-terminal domain. Indeed, the N-terminal do-
main of NCL is a long unstructured (300 amino acids) domain that,
besides its reported interaction with other proteins, may support the
binding speciﬁcity of the RBD and RGG domains that directly make con-
tact with the nucleic acid. 2) It has been demonstrated that short loops
tend to constrain G4 structures into a parallel conformation, regardless
of base composition [66,67], therefore the suggested preferential bind-
ing to short-looped G4s in the parallel conformation may derive from
the analysis of two dependent variables. 3) In our present workwe per-
formed a systematic analysis of loop sequence and oligonucleotide con-
formation working on a simpliﬁed (GGGTTT)n sequence. We
unambiguously showed that NCL prefers G4s with at least one long
loop (≥3 nts), while three short loops (1 nt) or three long loops (6
nts) are disfavored. The analysis on the simpliﬁed sequences allowed
us tomodify the conformation of the oligonucleotidesworking in differ-
ent salt (K+ or Na+) and crowding conditions (PEG 20%w/v) [68,72,75]
to show that NCL binding is in general independent of the oligonucleo-
tide conformation and that loop lengths is the driving force that en-
hances NCL binding to G4s. By extending the results from the
telomeric sequences to cellular oncogene and HIV-1 promoter G4s, we
were able to show that loop length is the major determinant in the en-
hancement of NCL binding to G4s even in more variable and complex
sequences. This observation is in line with the reported recognition of
G4s by the cellular protein EWS: EWS shares with NCL the RGG domain
whichmediates recognition of G4s [82] and binds to G4s independently
of base composition in long loops [64].
Finally, our results may shed some light on NCL recognition of re-
peats of G4 forming regions, such as the hexanucleotide repeat involved
in the neurodegenerative diseases amyotrophic lateral sclerosis and
frontotemporal dementia [16] and telomeric repeats [83]. We (Fig. 2A
presentwork) and others [65] have shown that regions containingmul-
tiple G-tracts can fold into several conformations involving the alterna-
tive use of different G-tracts. We here indicate that NCL binding
stimulates folding of these regions to G4s containing long loops (i.e.
someG-tractsmay be included to the loopmoiety) thereforemodifying
the overall 3D structure and steric hindrance of these nucleic acid re-
peated sequences. Interestingly, indeed, NCL preferentially stabilized
G4s that were less intrinsically stable, likely because of the possibility
in this condition to fold them in the best protein-ﬁtting conformation,
i.e. G4s with longer and loose loops: this conformational modiﬁcation
may represent a marker to molecular signaling and disease pathogene-
sis. Our data perfectly ﬁt with the very recent demonstration that pro-
tein binding to G4 and iMotif structures modify complex stability and
the overall nucleic acid conformation to provide a mechanosensor-reg-
ulated cellular mechanism [84].Please cite this article as: S. Lago, et al., The cellular protein nucleolin pr
Biophys. Acta (2016), http://dx.doi.org/10.1016/j.bbagen.2016.11.0365. Conclusions
Our work has unambiguously shown that loop length of G4 struc-
tures is a fundamental feature recognized byNCL to promote its binding
to G4-folded nucleic acids. Understanding the determinants that regu-
late NCL/G4 binding is the ﬁrst step towards the development of thera-
pies that speciﬁcally alter this molecular switch that triggers cellular
signaling, such as initiation of transcription in the HIV-1 promoter and
hence viral production, virus infection, tumor formation, maintenance
and metastasis, and neurodegeneration.
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